Swiss Competition Authority: WEKO fines Pfizer, Eli Lilly and Bayer for recommendation list for certain drugs
MLex Summary: The Swiss competition authority has fined pharmaceuticals companies Pfizer, Eli Lilly and Bayer 5.7 million Swiss Francs (3.77 million euros) for pricing practices for certain drugs. The regulator found...To view the full article, register now.
Already a subscriber? Click here to view full article